269 filings
Page 2 of 14
8-K
el7bc3k6h7vpnv7vep
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
v7dszoeq
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
t0uf bakil
12 Sep 22
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
7:01am
8-K
kxzpn
29 Aug 22
Departure of Directors or Certain Officers
5:01pm
8-K
qpt ac0vva0
15 Aug 22
TherapeuticsMD Announces Second Quarter 2022 Financial Results
7:15am
8-K
3sbpap
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
k3gww
29 Jul 22
Entry into a Material Definitive Agreement
8:58am
8-K
lcng6g7n 313janxb4
28 Jul 22
Entry into a Material Definitive Agreement
9:47am
8-K
44pkug
25 Jul 22
Entry into a Material Definitive Agreement
8:00am
8-K
hfxbhvp1x0ytzf
14 Jul 22
Entry into a Material Definitive Agreement
9:00am
8-K/A
d8p76g0y 40
6 Jun 22
Amendments to Articles of Incorporation or Bylaws
6:03am
8-K
bz5yym6z8
3 Jun 22
Entry into a Material Definitive Agreement
4:31pm
8-K
2850j1 v2n1
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
2ipnkrtwz48c7164b
20 May 22
Regulation FD Disclosure
10:30am
8-K
tlop 5mi5m7j
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
41kgm4y
9 May 22
Material Modifications to Rights of Security Holders
6:30am
8-K
yp3rl0mg rvgum8snv
27 Apr 22
Other Events
4:30pm
8-K
cmata7bn
20 Apr 22
Completion of Acquisition or Disposition of Assets
4:20pm
8-K
6zvtwqbw
14 Apr 22
TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million
4:25pm
8-K
b89by
18 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm